Cargando…

Addition of Capecitabine to Adjuvant Chemotherapy May be the Most Effective Strategy for Patients With Early-Stage Triple-Negative Breast Cancer: A Network Meta-Analysis of 9 Randomized Controlled Trials

BACKGROUND AND OBJECTIVE: Previous studies determined the therapeutic effects of capecitabine-based chemotherapy regimens on early-stage triple-negative breast cancer (TNBC). However, the optimal strategy of capecitabine-based chemotherapy remains uncertain. We conducted this network meta-analysis t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Zhiyang, Zheng, Jiehua, Ji, Zeqi, Chen, Lingzhi, Wu, Jinyao, Zou, Juan, Liu, Yiyuan, Lin, Weixun, Cai, Jiehui, Chen, Yaokun, Chen, Yexi, Lu, Hai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358934/ https://www.ncbi.nlm.nih.gov/pubmed/35957836 http://dx.doi.org/10.3389/fendo.2022.939048

Ejemplares similares

Global Trends in Research of Androgen Receptor Associated With Breast Cancer From 2011 to 2020: A Scientometric Analysis
por: Chen, Lingzhi, et al.
Publicado: (2022)

Comparative efficacy and safety of different combinations of three CDK4/6 inhibitors with endocrine therapies in HR+/HER-2 − metastatic or advanced breast cancer patients: a network meta-analysis
por: Liu, Yiyuan, et al.
Publicado: (2023)

Global research trends on anti-PD-1/anti-PD-L1 immunotherapy for triple-negative breast cancer: A scientometric analysis
por: Wu, Jinyao, et al.
Publicado: (2023)

Effect of Previous Cancer History on Survival of Patients with Different Subtypes of Breast Cancer
por: Lin, Weixun, et al.
Publicado: (2022)

Global trends in research of endoscopic thyroidectomy from 2013 to 2022: a scientometric and visualization analysis
por: Zheng, Daitian, et al.
Publicado: (2023)

Prognostic and Immune-Infiltrate Significance of miR-222-3p and Its Target Genes in Thyroid Cancer
por: Zhang, Taofeng, et al.
Publicado: (2021)

Development and validation of a novel endoplasmic reticulum stress-related lncRNA prognostic signature and candidate drugs in breast cancer
por: Cai, Jiehui, et al.
Publicado: (2022)

The Global, Regional, and National Burden and Trends of Breast Cancer From 1990 to 2019: Results From the Global Burden of Disease Study 2019
por: Xu, Shangbo, et al.
Publicado: (2021)

A scientometric analysis of research trends on emerging contaminants in the field of cancer in 2012–2021
por: Zheng, Daitian, et al.
Publicado: (2022)

Research trend of circulating tumor DNA associated with breast cancer from 2012 to 2021: A bibliometric analysis
por: Ji, Zeqi, et al.
Publicado: (2023)

Global research into the relationship between electronic waste and health over the last 10 years: A scientometric analysis
por: Tian, Huiting, et al.
Publicado: (2023)

Mapping global trends in research of stem cell therapy for COVID-19: A bibliometric analysis
por: Zhang, Xinkang, et al.
Publicado: (2022)

A scientometric analysis of research trends on targeting mTOR in breast cancer from 2012 to 2022
por: Zhang, Xizhou, et al.
Publicado: (2023)

Global trends in BRCA-related breast cancer research from 2013 to 2022: A scientometric analysis
por: Huang, Yujie, et al.
Publicado: (2023)

Trends in research of exosomes associated with breast cancer over the past decade: a scientometric analysis
por: Wu, Jiaxin, et al.
Publicado: (2023)

A bibliometric and visualization analysis on the association between chronic exposure to fine particulate matter and cancer risk
por: Luo, Xuman, et al.
Publicado: (2022)

Scientometric analysis of lipid metabolism in breast neoplasm: 2012–2021
por: Lin, Xiaobing, et al.
Publicado: (2023)

Reply letter to “Comment on bibliometric and visual analysis of vaccination hesitancy research”
por: Chen, Chaojian, et al.
Publicado: (2023)

Bibliometric and visual analysis of vaccination hesitancy research from 2013 to 2022
por: Chen, Chaojian, et al.
Publicado: (2023)

Identification of immune-related lncRNAs to improve the prognosis prediction for patients with papillary thyroid cancer
por: Li, Zhiyang, et al.
Publicado: (2021)

Efficacy of Sequential Capecitabine on Adjuvant Chemotherapy of Triple-Negative Breast Cancer
por: Xi, Xun, et al.
Publicado: (2022)

A Low Creatinine to Body Weight Ratio Predicts the Incident Nonalcoholic Fatty Liver Disease in Nonelderly Chinese without Obesity and Dyslipidemia: A Retrospective Study
por: Lin, Jianxiong, et al.
Publicado: (2020)

The efficacy of cognitive behavioral therapy for cancer: A scientometric analysis
por: Lin, Chuanghao, et al.
Publicado: (2022)

Identification of a basement membrane-related gene signature for predicting prognosis and estimating the tumor immune microenvironment in breast cancer
por: Cai, Jiehui, et al.
Publicado: (2022)

Clinical Prognostic Factors in Patients With Metastatic Adrenocortical Carcinoma Treated With Second Line Gemcitabine Plus Capecitabine Chemotherapy
por: Grisanti, Salvatore, et al.
Publicado: (2021)

Adjuvant capecitabine-containing chemotherapy benefit and homologous recombination deficiency in early-stage triple-negative breast cancer patients
por: de Boo, Leonora W., et al.
Publicado: (2022)

Aggressive Pituitary Macroadenoma Treated With Capecitabine and Temozolomide Chemotherapy Combination in a Patient With Nelson’s Syndrome: A Case Report
por: Mirallas, Oriol, et al.
Publicado: (2021)

Capecitabine in adjuvant radiochemotherapy for gastric adenocarcinoma
por: Oblak, Irena, et al.
Publicado: (2014)

Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group
por: Ünal, Çağlar, et al.
Publicado: (2023)

The role of capecitabine-based neoadjuvant and adjuvant chemotherapy in early-stage triple-negative breast cancer: a systematic review and meta-analysis
por: Huo, Xingfa, et al.
Publicado: (2021)

Non-Assisted Hatching Trophectoderm Biopsy Does Not Increase The Risks of Most Adverse Maternal and Neonatal Outcome and May Be More Practical for Busy Clinics: Evidence From China
por: Li, Shuo, et al.
Publicado: (2022)

Phase III Trial of Adjuvant Capecitabine After Standard Neo-/Adjuvant Chemotherapy in Patients With Early Triple-Negative Breast Cancer (GEICAM/2003-11_CIBOMA/2004-01)
por: Lluch, Ana, et al.
Publicado: (2020)

Triple-Negative PAM50 Non-Basal Breast Cancer Subtype Predicts Benefit from Extended Adjuvant Capecitabine
por: Asleh, Karama, et al.
Publicado: (2023)

Addition of Capecitabine in Breast Cancer First-line Chemotherapy Improves Survival of Breast Cancer Patients
por: Xu, Di, et al.
Publicado: (2019)

Docetaxel, Oxaliplatin and Capecitabine (TEX) triplet regimen as adjuvant chemotherapy in resected gastric adenocarcinoma
por: Thumaty, Divya Bala, et al.
Publicado: (2021)

Cost-effectiveness analysis of metronomic capecitabine as adjuvant chemotherapy in locoregionally advanced nasopharyngeal carcinoma
por: She, Longjiang, et al.
Publicado: (2022)

Prognostic model for the exemption of adjuvant chemotherapy in stage IIIC endometrial cancer patients
por: Yang, Xi-Lin, et al.
Publicado: (2022)

Early Follicular Phase Human Chorionic Gonadotropin Addition May Improve the Outcomes of In Vitro Fertilization/Intracytoplasmic Sperm Injection in Patients With “Unpredictable” Poor Response to Gonadotropin-Releasing Hormone Antagonist Protocol
por: Zhang, Chunhui, et al.
Publicado: (2021)

Most postoperative reserved “normal” metatarsal stumps of diabetic foot osteomyelitis are infected but have healing potential
por: Xu, Jun, et al.
Publicado: (2023)

The Clinical Value of Chemotherapy Combined With Capecitabine in Triple-Negative Breast Cancer—A Meta-Analysis
por: Zhang, Zilin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lbt2llb4vppvcg7um8pq3mco38